Factors Affecting the Price of DIFICID

Exelon (rivastigmine), used for Alzheimer’s and Parkinson’s-related dementia, has a price shaped by several factors.

Factors Affecting the Price of DIFICID

R&D costs for developing this cholinesterase inhibitor, including trials for efficacy and safety, contribute significantly. Patent protection initially allowed Novartis to set premium prices, though generic versions post-patent may lower costs. Production expenses, such as manufacturing oral tablets or transdermal patches with precise dosing, add to the base price. Market demand for dementia treatments and regional healthcare policies—like insurance coverage or government subsidies—also influence final costs for patients.

Related Columns

Fidaxomicin(DIFICID)

Indicated for the treatment of Clostridium difficile-associated diarrhea (CDAD)...

WeChat Scan
Free Inquiry

How to Purchase Dificid (Fidaxomicin)

Dificid (fidaxomicin) is a macrolide antibacterial agent used for the treatment of Clostridioides difficile - associated diarrhea (CDAD). It is indicated for adult patients and pediatric patients aged...

How to buy Fidaxomicin

Fidaxomicin is an antibiotic used to treat Clostridium difficile-associated diarrhea (CDAD) and was developed by Astellas of Japan. Since the drug is not yet available in China, patients need to ...

Fidaxomicin price

Fidaxomicin is an antibacterial drug used to treat Clostridium difficile-associated diarrhea (CDAD). It was developed by Astellas of Japan and approved by the US FDA in 2011. Fidaxomicin has...